The table presents the positions of various advocacy groups regarding biospecimen proposals, categorized by subgroups. Among citizen and non-specific patient or health advocacy and privacy advocates, a majority (55%) express support, with an additional 15% offering qualified support, while 30% are opposed. In contrast, advocacy groups focused on cancer and rare diseases show significantly less support, with only 13% in favor and 7% offering qualified support, while a substantial 80% oppose the proposals. Advocacy groups for other diseases and disorders demonstrate moderate endorsement, with 44% supportive and 22% providing qualified support, but a noteworthy 33% remain opposed. This data indicates a clear variation in attitudes toward biospecimen proposals depending on the specific focus of the advocacy group, with cancer and rare disease advocates demonstrating the most opposition.
Survey
